| Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats | Mustafa ARGUN,Kazım ÜZÜM,Mehmet Fatih SÖNMEZ,Abdullah ÖZYURT,DERYA KARABULUT,Zeynep SOYERSARICA,Kübra TUĞÇE ÇİLENK,Sunay UNALMIŞ,Özge PAMUKÇU,ALİ BAYKAN,Figen NARİN,FERHAN ELMALI,Nazmi NARİN | 234–241 |
| What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon? | Erdem ÖZEL,Ahmet TAŞTAN,Ali ÖZTÜRK,Emin Evren ÖZCAN,Samet UYAR,Ömer ŞENARSLAN | 244–249 |
| Impaired quality of life in patients with intermittent atrial fibrillation | CEM NAZLI,NİHAN KAHYA EREN,Selcen Yakar TÜLÜCE,Gökçen İdil YAĞIZ KOÇAĞRA,BARIŞ KILIÇASLAN,Uğur KOCABAŞ | 250–255 |
| Deterioration of heart rate recovery index in patients with erectile dysfunction | Şeref ULUCAN,Zeynettin KAYA,Ahmet KESER,Hüseyin KATLANDUR,Mustafa KARANFİL,İsmail ATEŞ | 264–269 |
| Computed tomography pulmonary embolism residua index (CTPER-index): a simple tool for pulmonary embolism residua description | Zdenek VAVERA,Pavel ELİAS,Pavel RYSKA,Jan VOJACEK | 270–275 |
| Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism | Neşe DURSUNOĞLU,Dursun DURSUNOĞLU,Ali İhsan YILDIZ,Simin ROTA | 276–282 |
| The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease | SİNEM ÖZBAY ÖZYILMAZ,Mehmet Fethi ALİŞİR,Osman AKIN SERDAR,Esra UZASLAN | 283–289 |
| Heart rate variability improvement in children using transcatheter atrial septal defect closure | İsa ÖZYILMAZ,Yakup ERGÜL,Hasan Tahsin TOLA,Murat SAYGI,Erkut ÖZTÜRK,İbrahim Cansaran TANIDIR,Öykü TOSUN,SİNEM ÖZBAY ÖZYILMAZ,Mehmet GÜL,ALPER GÜZELTAŞ,Ender ÖDEMİŞ,İhsan BAKIR | 290–295 |
| Successful treatment of total occluded innominate artery in a patient with subclavian steal syndrome | Taner ŞEKER,Hazar HARBALIOĞLU,Mustafa GÜR,Murat ÇAYLI | 296–297 |
| The role of left atrial deformation parameters in the prediction of atrial fibrillation recurrence after cryoballoon ablation therapy | Can Ramazan ÖNCEL | 298–298 |
| The role of left atrial deformation parameters in the prediction of atrial fibrillation recurrence after cryoballoon ablation therapy (Author`s Reply) | Demet Menekşe GEREDE | 298–299 |
| Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity | Mustafa GÜLGÜN,Kürşat FİDANCI,Alparslan Fatih GENÇ,Vural KESİK | 299–299 |
| Natriuretic peptide and cardiac troponin levels in doxorubicin-induced cardiotoxicity (Author`s Reply) | Mustafa ARGUN,Kazım ÜZÜM,ALİ BAYKAN,Nazmi NARİN | 299–300 |
| Late huge thrombus formation after percutaneous closure of an atrial septal defect with an Amplatzer septal occluder: Implications of Kounis syndrome (Author`s Reply) | Fahrettin UYSAL | 300–302 |
| Late huge thrombus formation after percutaneous closure of an atrial septal defect with an Amplatzer septal occluder: Implications of Kounis syndrome | Nicholas G. KOUNIS,Dimitrios LIANAS,George N. KOUNIS,George D. SOUFRAS | 300–301 |
| Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction | Levent CERİT | 302–302 |
| Admission serum potassium level is associated with in-hospital and long-term mortality in ST-elevation myocardial infarction (Author`s Reply) | MAHMUT ULUGANYAN | 302–303 |
| ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1) polymorphism and clopidogrel concentration in acute coronary syndrome: molecular change can explain the observed therapeutic concentration | Beuy JOOB,Viröj WIWANITKIT | 303–304 |
| Emergency endovascular treatment of peripheral arterial injuries occurring during the Syrian civil war: Gaziantep Dr. Ersin Arslan Education and Research Hospital Experience | ERTAN VURUŞKAN,Erhan SARAÇOĞLU,Mehmet KÜÇÜKOSMANOĞLU,FETHİ YAVUZ,Zülfiye KUZU,İSA SİNCER | 304–304 |